Related Experiment Videos
[Endogenous toxemia in acute disorders of cerebral circulation]
Abstract:
Critical conditions that develop because of hypoxia of different genesis are accompanied by endogenous intoxication induced to a considerable degree by the appearance in the blood of an excess amount of medium-sized molecules (MSM). An appreciable increase of the content of MSM was demonstrated since the very first days after the brain stroke as a result of examining 100 patients who suffered brain stroke, including 83 patients during the first week of the disease and 17 patients of the reference group with a history of acute impairment of cerebral circulation which had occurred over a month before. A reverse correlation was established between the level of endogenous intoxication and the clinical status of the patients which could be observed every day during the acute disease phase. The critical level of MSM was determined in the patients' blood plasma. In the majority of cases, the attainment of the above level resulted in a lethal outcome irrespective of the pattern of acute impairment of cerebral circulation. The data obtained make it possible to recommend using the level of MSM as one of the simple and rapid quantitative methods for assessment of the patients' status gravity and monitoring of persons with acute impairment of cerebral circulation.
Insights
Elevated medium-sized molecules (MSM) indicate endogenous intoxication in stroke patients. Monitoring MSM levels can help assess patient status and predict outcomes in acute cerebral circulation impairments.
Area of Science:
- Biochemistry
- Neurology
- Critical Care Medicine
Context:
- Hypoxia-induced critical conditions are often associated with endogenous intoxication.
- Medium-sized molecules (MSM) accumulate in the blood during such states.
- Brain stroke is a critical condition where endogenous intoxication plays a significant role.
Purpose:
- To investigate the correlation between medium-sized molecules (MSM) and endogenous intoxication in patients with acute impairment of cerebral circulation.
- To determine the clinical significance of MSM levels in stroke patients.
- To evaluate MSM as a potential biomarker for assessing disease severity and prognosis.
Summary:
- A study of 100 brain stroke patients revealed a significant increase in MSM levels, particularly within the first week of the disease.
- A reverse correlation was observed between MSM levels and the patients' clinical status during the acute phase.
- A critical threshold for MSM in blood plasma was identified, with levels at or above this threshold frequently leading to lethal outcomes, regardless of the stroke's specific pattern.
Impact:
- The findings suggest that MSM levels can serve as a simple and rapid quantitative marker for assessing the severity of a patient's condition.
- Monitoring MSM levels could aid in the prognosis and management of patients experiencing acute impairment of cerebral circulation.
- This research highlights the potential of biochemical markers in critical care for improving patient monitoring and outcome prediction.